Cognizant on Tuesday gave its consent to acquire Zenith Technologies, a privately-held life sciences manufacturing technology services company headquartered in Cork, Ireland.
Zenith Technologies specializes in implementing digital technologies to manage, control and optimize drug and medical device production for maximum operational efficiency and regulatory compliance. The acquisition extends Cognizant’s capabilities for designing, implementing and managing end-to-end operational and information technology systems for connected bio-pharmaceutical and medical device manufacturers.
‘’The combined Cognizant-Zenith Technologies expertise will deliver a range of Industry 4.0 capabilities, right from factory design consultation, machine sensor and controller instrumentation, supervisory control, and data acquisition, to manufacturing execution systems, batch automation, enterprise resource planning integration and managed services’’, a Cognizant release here said.
The company’s operating hubs in Ireland, Germany, India, Singapore, the United States and other sites around the world were located near manufacturing facilities of many Cognizant clients. Cognizant is a leading services provider to the life sciences industry, working with all of the world’s top 30 life sciences companies. It said “Industry 4.0 solutions, encompassing Internet of Things (IoT), automation and analytics, are a strategic focus area for Cognizant,” according to Brian Humphries, Chief Executive Officer, Cognizant. “In acquiring Zenith Technologies, we expand Cognizant’s IoT portfolio and extend our life sciences domain expertise by becoming a single source provider of end-to-end smart factory capabilities’’, he said.